Beta Bionics Inc (BBNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||
| Net Income | -73,200 | -54,756 | -44,099 |
| Depreciation Amortization | 2,875 | 2,283 | 2,091 |
| Accounts receivable | -5,162 | -7,618 | -4,494 |
| Accounts payable and accrued liabilities | 2,098 | 1,515 | 716 |
| Other Working Capital | -8,992 | -12,148 | -5,305 |
| Other Operating Activity | 31,456 | 22,451 | 18,646 |
| Operating Cash Flow | $-50,925 | $-48,273 | $-32,445 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | 164,703 | 68,605 | -69,295 |
| PPE Investments | -282,035 | -72,081 | -398 |
| Purchase Of Investment | -45,473 | N/A | N/A |
| Investing Cash Flow | $-162,805 | $-3,476 | $-69,693 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 214,874 | 102 | 29 |
| Other Financing Activity | 0 | 55,513 | 101,000 |
| Financing Cash Flow | $214,874 | $55,615 | $101,029 |
| Beginning Cash Position | 30,532 | 26,666 | 27,775 |
| End Cash Position | 31,676 | 30,532 | 26,666 |
| Net Cash Flow | $1,144 | $3,866 | $-1,109 |
| Free Cash Flow | |||
| Operating Cash Flow | -50,925 | -48,273 | -32,445 |
| Capital Expenditure | -282,035 | -72,131 | -402 |
| Free Cash Flow | -332,960 | -120,404 | -32,847 |